Document: Annual activity report 2024-2025/6/27

Document: Dossier administrative validation checklist for initial marketing authorisation applications by applicants-2025/6/27

Document: List of medicines currently in PRIME scheme-2025/6/27

Page: Pre-authorisation guidance-2025/6/27

Document: Guidance notes on the use of Veterinary Dictionary for Drug Regulatory Activities (VeDDRA) terminology for reporting suspected adverse events in animals and humans - Rev.16-2025/6/27

Document: Veterinary Dictionary for Drug Regulatory Activities (VeDDRA) dataload friendly file including deprecated terms-2025/6/27

Document: Non-current Veterinary Dictionary for Drug Regulatory Activities (VeDDRA) low level terms (LLT) and codes-2025/6/27

Document: List of changes to combined Veterinary Dictionary for Drug Regulatory Activities (VeDDRA) list of clinical terms for reporting suspected adverse events in animal and humans to veterinary medicinal products for 2024-2025/6/27

Document: Combined Veterinary Dictionary for Drug Regulatory Activities (VeDDRA) list of clinical terms for reporting suspected adverse events in animals and humans to veterinary medicinal products - Rev.15-2025/6/27

Document: Combined VeDDRA list of clinical terms for reporting suspected adverse events in animals and humans to veterinary medicinal products-2025/6/27